“The 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome: Implications for the Inclusion of Participants in Research vs Diagnosis in Clinical Practice”, Can Rheumatol Today, vol. 1, no. 3, pp. 20–25, Dec. 2024, doi: 10.58931/crt.2024.1355.